Takeda's No. 1 Position In Japan Threatened By Novartis Inroads
This article was originally published in PharmAsia News
Executive Summary
Takeda Pharmaceutical position as the No. 1 drug maker in Japan could face a challenge from Switzerland's Novartis as it moves to expand its Japanese presence